Eir Partners Closes Oversubscribed $496 Million Investment Program IIDedicated Investment Program II Will Further Eir Partners' Strategy of Partnering with Companies Across the Healthcare Technology & Technology Enabled Services MarketplaceMIAMI, May 21, 2024-- Eir Partners Capital, LLC ('Eir', 'Eir Partners' or the 'Firm'), a middle market private equity firm focused on healthcare technology and tech-enabled services, today announced the final closing of Eir Partners Investment Program II with $496 million in capital commitments.

Eir Partners Closes超额认购4.96亿美元投资计划II专用投资计划II将进一步推动Eir Partners在医疗保健技术和技术支持服务市场与公司合作的战略迈阿密，2024年5月21日——Eir Partners Capital，LLC（“Eir”，“Eir Partners”或“公司”），一家专注于医疗保健技术和技术支持服务的中等市场私人股本公司，今天宣布最终关闭Eir Partners Investment Program II，承诺资本4.96亿美元。

Eir previously raised $255 million in capital commitments for its inaugural program, Eir Partners Program I, which closed in 2021 and invested in five platform investments..

Eir之前为其成立计划Eir Partners program I筹集了2.55亿美元的资本承诺，该计划于2021年结束，并投资于五个平台投资。。

The oversubscribed program was raised in less than four months and secured commitments from a diversified range of investors including leading financial institutions, insurance companies, family offices, funds-of-funds, endowments and foundations, and seasoned industry executives.

该超额认购计划在不到四个月的时间内筹集资金，获得了包括领先金融机构、保险公司、家族理财办公室、基金、捐赠基金和基金会以及经验丰富的行业高管在内的多种投资者的承诺。

'We are thrilled to receive support from a distinguished group of investors to continue our strategy of partnering with exceptional businesses and teams,' said Brett Carlson, Founder & Chief Executive Officer of Eir Partners. 'Their commitment will help grow and establish Eir as a leading health-tech investment firm in the market.'.

Eir Partners创始人兼首席执行官布雷特·卡尔森（BrettCarlson）说，我们很高兴能得到一群杰出投资者的支持，继续我们与优秀企业和团队合作的战略他们的承诺将有助于发展和建立Eir，使其成为市场上领先的健康技术投资公司。”。

Eir Partners Investment Program II will continue to invest in disruptive companies that have proven market fit and scale demonstrating outsized organic growth potential coupled with accretive M&A opportunities. Eir seeks to partner with businesses where the firm's operating experience and executive advisor network can make an impact across all aspects of the business including technology, finance, sales, and human capital..

Eir Partners Investment Program II将继续投资于具有市场适应性和规模的颠覆性公司，这些公司表现出巨大的有机增长潜力以及不断增长的并购机会。Eir寻求与公司的运营经验和执行顾问网络能够对业务的各个方面产生影响的企业合作，包括技术、财务、销售和人力资本。。

Lazard Frères & Co. LLC acted as the exclusive placement advisor, and Kirkland & Ellis LLP served as legal counsel in the formation of Eir Partners Investment Program II.

Lazard Frères&Co.LLC担任独家配售顾问，Kirkland&Ellis LLP担任Eir Partners Investment Program II的法律顾问。

About Eir Partners

关于Eir Partners

Eir Partners Capital, LLC is a Miami-based private equity company focused exclusively on healthcare technology and tech- enabled services. Eir combines its operational expertise with bottoms up thematic sourcing efforts to accelerate value creation. Since inception, Eir has completed transactions across payer, provider, employer and pharma tech, including leading industry names such as Apixio, Capta, GiftHealth, Helpware, and ReviveHealth.

Eir Partners Capital，LLC是一家总部位于迈阿密的私人股本公司，专注于医疗保健技术和技术支持服务。Eir将其运营专业知识与自下而上的主题采购工作相结合，以加速价值创造。自成立以来，Eir已经完成了支付方、提供商、雇主和制药技术的交易，包括领先的行业名称，如Apixio、Capta、GiftHealth、Helpware和ReviveHealth。

Targeted stages of investment include growth equity through control buyouts and equity check sizes range from $25 - $100 million..

投资的目标阶段包括通过控制权收购增长股权，股权支票规模从2500万美元到一亿美元不等。。

For more information, please visit the Eir Partners website at https://www.eirpartners.com/ or the Eir Partners LinkedIn page at https://www.linkedin.com/company/eir-partners.Contact:

有关更多信息，请访问Eir Partners网站https://www.eirpartners.com/或Eir Partners LinkedIn页面https://www.linkedin.com/company/eir-partners.Contact:

Chris Tofalli

Chris Tofalli

Chris Tofalli Public Relations, LLC

Chris Tofalli公共关系有限责任公司

914-834-4334

914-834-4334

chris@tofallipr.com

chris@tofallipr.com